Regional Neuroblastoma: Clinical Trials

13 trials for Regional Neuroblastoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed. 4 Phase 1, 3 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 33Completed 3
Not applicable1Completed 1

Follow Regional Neuroblastoma: new trials by email Literature Review of Regional Neuroblastoma trials Research Report on Regional Neuroblastoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Busulfan - Ganglioneuroblastoma, Localized Resectable Neuroblastoma
Phase 1CompletedChildren's Oncology Group992011-12-212026-01-23
Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma
Cytology Specimen Collection Procedure, Pharmacological Study - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
CompletedNational Cancer Institute (NCI)122011-05-262019-10-01
Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
Isotretinoin, Laboratory Biomarker Analysis, Pharmacological Study - Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma
Phase 1CompletedNational Cancer Institute (NCI)292010-12-012015-11-24
Study of Specimens From Young Patients With Neuroblastoma
laboratory biomarker analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
CompletedChildren's Oncology Group3502008-12-012016-05-18
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cisplatin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
Phase 3CompletedChildren's Oncology Group6652007-11-052022-04-28
Study of DNA in Blood Samples From Patients With Neuroblastoma
laboratory biomarker analysis, polymerase chain reaction, polyacrylamide gel electrophoresis - Disseminated Neuroblastoma, Localized Resectable Neuroblastoma
CompletedChildren's Oncology Group3292007-06-012016-05-18
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
CompletedChildren's Oncology Group93502006-12-112018-08-07
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
etoposide, cyclophosphamide, carmustine - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Not applicableCompletedRoswell Park Cancer Institute1742006-06-292021-04-22
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
Phase 3CompletedChildren's Oncology Group532004-03-152023-04-18
R(+)XK469 in Treating Patients With Advanced Neuroblastoma
R(+)XK469 - Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma
Phase 1CompletedNational Cancer Institute (NCI)852001-12-012013-12-16
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Aldesleukin, Dinutuximab, Isotretinoin - Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma
Phase 3CompletedNational Cancer Institute (NCI)14492001-10-262026-03-05
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
monoclonal antibody Ch14.18, isotretinoin, aldesleukin - Disseminated Neuroblastoma, Recurrent Neuroblastoma
Phase 1CompletedNational Cancer Institute (NCI)62001-01-012013-01-16
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Ganglioneuroblastoma, Localized Resectable Neuroblastoma
CompletedChildren's Oncology Group100002000-11-062026-07-09

Narrower conditions

Neuroblastoma (12)  ·  Ganglioneuroblastoma (2)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Hodgkin Disease (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)

Broader conditions

Neoplasms (12)  ·  Neoplasms by Histologic Type (12)  ·  Neoplasms, Germ Cell and Embryonal (12)  ·  Neoplasms, Glandular and Epithelial (12)  ·  Neoplasms, Nerve Tissue (12)  ·  Neoplasms, Neuroepithelial (12)  ·  Neuroectodermal Tumors (12)  ·  Neuroectodermal Tumors, Primitive (12)  ·  Neuroectodermal Tumors, Primitive, Peripheral (11)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Amyloidosis (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Chronic Disease (1)

Interventions

Isotretinoin (5)  ·  Cyclophosphamide (4)  ·  Melphalan (3)  ·  1,2-diaminocyclohexaneplatinum II citrate (2)  ·  Busulfan (2)  ·  Carboplatin (2)  ·  Cisplatin (2)  ·  Doxorubicin (2)  ·  Etoposide (2)  ·  Platinum (2)  ·  Thiotepa (2)  ·  Topotecan (2)  ·  Vincristine (2)  ·  aldesleukin (2)  ·  dinutuximab (2)

Sponsors

Children's Oncology Group (7)  ·  National Cancer Institute (NCI) (5)  ·  Roswell Park Cancer Institute (1)

Countries

United States (13)  ·  Canada (5)  ·  Australia (4)  ·  New Zealand (3)  ·  Puerto Rico (3)  ·  Switzerland (2)  ·  Netherlands (1)  ·  Saudi Arabia (1)

Top investigators

Michael Hogarty, MD (2)  ·  Alice L Yu (1)  ·  Andrew Gilman (1)  ·  Brian D Weiss (1)  ·  Frank M Balis (1)  ·  John Maris (1)  ·  Julie Park (1)  ·  Julie R Park (1)  ·  Michael Hogarty (1)  ·  Pedro A De Alarcon (1)  ·  Philip McCarthy (1)  ·  Susan Cohn (1)

Results publications

PMID 20879881, PMID 29376112, PMID 31454045, PMID 32530765, PMID 34028986, PMID 35839426, PMID 37883734, PMID 38815188, PMID 40036726, PMID 42487567

NIH funding

U10CA098543 (5), U10CA180886 (5), P01CA081403 (1), P30CA016056 (1), P30CA016520 (1), U01CA069852 (1), U10CA013539 (1), U10CA030969 (1), UG1CA189958 (1)